1.
Moussa M, Chakra MA, Dabboucy B, Fares Y, Dellis A, Papatsoris A. The safety and effectiveness of mirabegron in Parkinson’s disease patients with overactive bladder: a randomized controlled trial. SJU [Internet]. 2022 Jan. 2 [cited 2024 Sep. 10];56(1):66-72. Available from: https://medicaljournalssweden.se/SJU/article/view/11857